Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|November 18, 2009
In vitro pharmacological selectivity profile of oseltamivir prodrug (Tamiflu) and active metaboliteLothar Lindemann, Helmut Jacobsen, Diana Schuhbauer, et al.
Neuropharmacology|December 6, 2020
Symmetric signal transduction and negative allosteric modulation of heterodimeric mGlu1/5 receptorsRuth C Werthmann, Manuel Tzouros, Jens Lamerz, et al.
Alzheimer'S Research & Therapy|February 19, 2025
γ-Secretase modulator resistance of an aggressive Alzheimer-causing presenilin mutant can be overcome in the heterozygous patient state by a set of advanced compoundsJohannes Trambauer, Rosa Maria Rodriguez Sarmiento, Holly J Garringer, et al.
Brain, Behavior, and Immunity|August 16, 2016
Blocking metabotropic glutamate receptor subtype 5 relieves maladaptive chronic stress consequencesDaniel Peterlik, Christina Stangl, Amelie Bauer, et al.
Plos One|July 12, 2013
The impact of Bdnf gene deficiency to the memory impairment and brain pathology of APPswe/PS1dE9 mouse model of Alzheimer's diseaseTomi Rantamäki, Susanna Kemppainen, Henri Autio, et al.
Drug Safety|November 26, 2008
Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive reviewStephen Toovey, Craig Rayner, Eric Prinssen, et al.
Frontiers in Pharmacology|June 15, 2026
Pharmacology of nivegacetor (RG6289), a potent and selective gamma secretase modulator in clinical development for the treatment of Alzheimer's diseaseLothar Lindemann, Julie Lambotte, Judith Rothe, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2011
CTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitorLothar Lindemann, Georg Jaeschke, Aubin Michalon, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 6, 2017
mGluR5 Modulation of Behavioral and Epileptic Phenotypes in a Mouse Model of Tuberous Sclerosis ComplexElyza Kelly, Samantha M Schaeffer, Sameer C Dhamne, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 18, 2017
Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 ResultsEriene A Youssef, Elizabeth Berry-Kravis, Christian Czech, et al.
Pageof 4